Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01695863 · ClinicalTrials.gov registry record · Phase 4

Efficacy and Patient Satisfaction of Miralax and Gatorade Versus Movi Prep

A Phase 4 study of Colorectal Cancer, sponsored by Rush University Medical Center.

Completed
Registry status
Phase 4
Development phase
150
Enrollment target
1
Study location

NCT01695863: Completed Phase 4 study of Colorectal Cancer, sponsored by Rush University Medical Center.

NCT01695863 is a Phase 4 study of Colorectal Cancer that has completed, run by Rush University Medical Center. The registered enrollment target is 150 participants, below the 1,544-participant average among 381 other Colorectal Cancer trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01695863, a Phase 4 study of Colorectal Cancer, has completed, sponsored by Rush University Medical Center.

COMPLETED
Registry status
Phase 4
Development phase
150 participants
Enrollment target
1
Study location

Study Summary

This study will be comparing patient satisfaction, efficacy comparing miralax with gatorade versus Movi Prep for outpatient colonoscopy.

Primary Outcome

To assess the bowel prep efficacy in cleansing the colon for colonoscopy - Scale used is the Boston Bowel Preparation Scale (BBPS), Integer Scale from 0-3, where 3 indicated the best outcome and 0 the worst. The BBPS was estimated during the procedure (Colonoscopy) by an endoscopist and a nurse and retrospectively by a second endoscopist postoperatively. Scores were averaged by for each subject by location (Right colon, Transverse colon, and Left colon) and then for each group/arm by location.

Conditions Studied

Interventions

  • DRUG comparing 2 drugs on their effect on the bowel preparation for colonoscopy

Study Locations (1)

Illinois

  • Rush Unversity Medical Center - Chicago

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2012-02
Est. Completion 2014-01
Phase Phase 4
Rush University Medical Center

320 total trials

What the finished NCT01695863 record still lists

NCT01695863 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 1,544-participant average among 381 other Colorectal Cancer trials with a reported enrollment target (90% lower).

The record links to 1 condition, with Colorectal Cancer appearing as the primary indexed condition, and to 1 intervention - of which comparing 2 drugs on their effect on the bowel preparation for colonoscopy is the first listed.

NCT01695863 reports a single indexed study location in Illinois.

Frequently Asked Questions

What is clinical trial NCT01695863 about?

NCT01695863 is a clinical study titled "Efficacy and Patient Satisfaction of Miralax and Gatorade Versus Movi Prep". This study will be comparing patient satisfaction, efficacy comparing miralax with gatorade versus Movi Prep for outpatient colonoscopy.

What is the current status of trial NCT01695863?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 150 participants. The study started on 2012-02. Estimated completion is 2014-01.

What conditions does trial NCT01695863 study?

This clinical trial studies the following conditions: Colorectal Cancer.

What interventions are being tested in trial NCT01695863?

The interventions under investigation include: comparing 2 drugs on their effect on the bowel preparation for colonoscopy (DRUG).

Who is sponsoring clinical trial NCT01695863?

This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01695863 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Colorectal Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01695863's enrollment target sits among peer trials

150 169th of 381 higher than 209 of 381 other Colorectal Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Colorectal Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00412594 · 150 participants · Phase 2

    Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia

  • NCT01484730 · 150 participants

    A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion

  • NCT01985919 · 150 participants

    Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples

  • NCT02016248 · 150 participants · NA

    SBRT Boost for Unfavorable Prostate Cancer'

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01695863, the US trial registry maintained by the National Library of Medicine. NCT01695863 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.